FDA Eyes Manufacturing Innovation to Boost Drug Development

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.

Related Content:

ManufacturingQuality SystemsRegulatory WatchPharmaceutical Technology-05-02-2004
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Increasing mRNA Product Stability with Lyophilization